Silver suffadiazine cream has been a standard treatment for burns over the past two decades. Although many studies have described the phenomenon of silver absorption from burn wounds treated with silver sulfadiazine, they failed to examine the chemistry underlying the absorption process: Silver chloride was assumed to form at the burn wound and absorption of silver was believed to be negligible. Here we have developed chemical model systems to investigate the interactionsof silver sulfadiazme and silver chloride in direct contact with synthetic serum electrolyte solution (SSES), with SSES plus endogenous ligands or beef blood plasma, and with human serum. The results indicate that silver absorption from an acute burn site can be significant, because human serum is capable of solubilizing silver. This finding is of concern, given the potential for silver toxicity as a direct consequence of applying silver sulfadiazine to extensive burn wounds.
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Skin has an important homeostatic function to perform, isolating an organism's internal environment from an often hostile external environment. It prevents the loss of important fluids and electrolytes and inhibits the introduction of noxious elements such as bacteria or chemical substances.
Burn wounds represent a breakdown of the skin's homeostatic function, resulting in such problems as fluid and electrolyte losses and infection, which may be life threatening alone or in combination.
The use of silver salts as a topical antiseptic has a long history (1), whereas the discovery of sulfonamide antibacterials in the 1940s ushered a new era of control of infection on burn wounds; however, these treatments were not without their problems. Silver nitrate may stain linen and clothing and cause pain on application; it can also lead to potentially lethal electrolyte disturbances and methemoglobinemia (2). Sulfonamide antibiotics may inhibit key enzymes such as carbonic anhydrase.
In 1968, Fox (3) combined silver with sulfadiazine and developed the topical antibacterial agent silver sulfadiazine, which appeared to combine the antibacterial properties of both the separate agents but with increased potency and negligible adverse effects. Silver sulfadiazine was painless on application, was clean to use, and dramatically decreased the rate of sepsis, compared the absorption of silver from burn wounds on guinea pigs treated topically with silver sulfadiazine and silver sulfathiazole and demonstrated isotope uptake in the liver, blood, kidneys, and urine (11) .
Silver is usually a trace element in humans; in excess it has the potential to cause lethal side effects. Silver has a tendency to accumulate in hepatic and splenic tissue (12, 13), and is mainly eliminated fecally (14) through the biliary tree, although some renal accumulation and excretion occur. Accumulation in the liver leads to decreased synthesis of ceruloplasmin (15) and inhibition of glutathione peroxidase (16). Inhibition of this enzyme leads to hepatocellular damage that, if extensive, may result in liver necrosis and failure. Accumulation in the kidney has led to toxicity to the proximal tubule of the individual nephrons, with the potential for renal failure (17) .
The purpose of the present study was to gain an understanding at the chemical level of the mechanism of absorption of silver from burn wounds treated with silver sulfadiazine.
We examined several models to investigate the chemical interaction between various silver salts in contact with sodium nitrate (a noninteracting medium), synthetic serum electrolyte solution (SSES), SSES plus endogenous ligands (e.g., glutathione, cysteine, methionine, and histamine)
to simulate the chemical environment at an acute burn site, SSES plus beef blood plasma, and human serum. The interaction between silver sulfadiazine and erythrocytes is currently under study and will be the subject of a further paper.
Materials and Methods Apparatus
Silver analysis was carried out with a Model 5100PC were used. Sulfadiazine analysis was performed with a Model U-3200 spectrophotometer (Hitachi, Tokyo, Japan). All glassware was washed in nitric acid (1.5 molIL) for 48 h and then thoroughly rinsed with deionized water.
Reagents
To prepare all solutions, we used water purified in a high-grade Miffi-Q De-ionizer system (Millipore, Melbourne, Australia) with a resistance >14 Mfl. All chemicals used to synthesize the required silver salts and any solutions needed for this study were of analytical grade or better. High-purity argon (CIG, Melbourne, Australia) was used as the purge gas for silver analysis in graphite furnace-AAS, and instrument-grade air and industrialgrade acetylene (both from CIG) were used for the flame when flaine-AAS was required.
Standards.
Silver standards for graphite furnace-AAS were prepared from a 50 g/L silver nitrate stock solution (equivalent to 31.8 /LgIL silver) that had been freshly prepared from analytical-grade silver nitrate (Deak International, Melbourne, Australia) dissolved in 2 milL "Aristar" nitric acid. A working curve was regularly prepared by using the AAS autosainpler, which diluted the 50 p.gfL stock solution with the nitric acid to give silver nitrate concentrations of 5, 10, 15, 20, 25, 30, 40, and 50 g/L.
Silver standards for flame-AAS were prepared from a 100 mgfL silver nitrate stock solution (equivalent to 63.5 mgfL silver) freshly prepared from dissolving the analytical-grade silver nitrate in 2 milL "Aristar" nitric acid. The stock solution was then serially diluted to give concentrations of 1, 2, 3, 4, 5, and 10 mg(L silver nitrate.
Sulfadia.zine standards were prepared from a stock solution freshly prepared from Sigma-grade sulfadiazine (Sigma Chemical Co., St. Louis, MO) in 3 mL of 2 mol/L sodium hydroxide per 100 mg of sulfadiazine.
This was diluted with Milli-Q water to give sulfadiazine concentrations of 1, 2, 3, 4, 5, and 10 rngfL. Silver salts. Silver sulfadiazine and silver chloride were prepared by reacting equimolar concentrations (0.1 mol/L) of ammoniacal solutions of silver nitrate and the appropriate anion in the dark (18). The white pastes that formed were ifitered off and washed several times with Milli-Q water, before being dried at 60#{176}C for 10 h under reduced pressure. Silver sulfadiazine was a white "fluffy" solid; the silver chloride was white and "clumpy."
Sample Preparation
We accurately weighed -100 mg of silver sulfadiasme and placed this in a 200-mL volumetric flask that we then filled with the medium being investigated. The pH of the solution was adjusted with 0.2 molIL sodium hydroxide solution to within the range of 7 to 8 (see Tables  1 and 2 ), and stored in the dark at laboratory temperature (-22#{176}C) for 2 weeks, with daily shaking to equilibrate the sparingly soluble silver salt with the medium. Once equilibrated, one portion of the solution was used to measure the pH; another portion was passed through a 0.45-pm Teflon filter and the filtrate was acidified to prevent silver adsorption onto the glassware.
The filtrate was analyzed for silver and sulfadiazine.
We followed the same procedure for silver chloride, weighing -40 mg of silver chloride to ensure that the same number of moles of silver salt was equilibrated in each solution.
The Both silver salts were equilibrated with each of these media except for solution f, where only silver sulfadiazme was used. The amounts of glutathione, cysteine, methionine, and histamine used gave a 1:1 molar ratio of silver to ligands. Triplicate experiments were carried out for every solution analyzed.
Analytical Procedure
For silver analysis by graphite furnace-AAS we used a wavelength of 328.1 nm, a slitwidth of 0.7 nm, and 20-L sample volume. The method was similar to that described by Wan et al. (10) for the determination of silver in blood and urine. Samples with a silver concentration >50 pgfL (as silver nitrate) were diluted to less than that concentration before analysis. The optimum conditions found were 140#{176}C for the drying temperature, 600#{176}C for the ashing temperature, and 1900#{176}C for the atomization temperature. The purge gas was highpurity argon for all steps except the ashing step, where instrument-grade air was used to remove any volatile materials such as organic matter. The gas flow rate was 300 mL'min for all steps except the read step, when the flow was stopped for 5s while the analytical signal was read. Automatically integrated peak areas were used for calculation of the results. The tube clean-up step used a temperature of 2650#{176}C. This procedure was used for both standards and samples. For silver analysis by flame-AAS we used a wavelength of 328.1 nm with a slitwidth of 0.7 nrn. Samples with silver concentrations >10 mg/L (as silver nitrate) were diluted before analysis. The signal peak areas were automatically integrated over 5 s to calculate the results.
Sulfadiazine analysis was by a modified Bratton and Marshall method (19) , with measurements at three wavelengths:
Readings at 420 and 650 nm were used to set the baseline, and the peak height was measured at 542 nm.
Results
When silver sulfadiazine was equilibrated with the simplest medium, 0.1 molIL NaNO3, the mean concentrations of silver and sulfadiazine in solution over the pH range 7-8.2 were 2.30 and 2.35 jmolfL, respectively (see Table 1 ). These values were similar to the concentrations of silver and sulfadiazine calculated from the solubility product for silver sulfadiazine in the same medium:
2.85 moI/L (4). When the medium was jmolJL, which is almost the maximum possible concentration for sulfadiazine in this experiment. Moreover, the solid that remained at equilibrium when exposed to light (once the experiment had been completed) changed from white to purple-blue, consistent with the formation of silver chloride. The other anions present in SSES were too low in concentration to cause silver precipitation.
The fact that sulfadiazine had reached its maximum possible concentration indicated that solid silver sulfadiazine had completely dissociated into solution, and the observation that silver chloride had precipitated meant that the calculated silver concentration in this medium would be dependent on the solubility product of silver chloride. In SSES, the chloride concentration was 0.103 moIIL, and so the expected silver concentration, calculated on the basis of the solubility product of silver chloride, was 0.0017 tmoIIL, -1000-fold less than the experimental value of 1.48 tmoIJL. This 1000-fold discrepancy is addressed in the Discussion.
When the ligands glutathione, cysteine, histamine, and methionine (see Fig. 1 for structures) were individually included in SSES in an equimolar ratio of ligand to silver, the solubility of silver increased. For all experiments in which the ligands were present in SSES, sulfadiazine almost reached its maximum possible concentration, indicating a complete dissociation of solid silver sulfadiazine into solution. When glutathione was present in SSES, the silver, too, almost reached its maximum expected concentration in the pH range of 7-S (see Table 1 ). Although the other ligands reacted with silver, precipitation limited the amount of soluble silver found in solution. Cysteine formed a sparingly soluble precipitate with silver at low pH, whereas at higher pH the solubility of silver increased by -150-fold.
This behavior was not seen for either methionine or histamine, which produced low concentrations of silver in solution at pH 7-S. The mean concentration of silver with methionine or histamine present in solution was 2.42 and 2.65 moVL, respectively.
When dried beef blood protein was included in SSES to form an artificial serum, the solubility of silver increased by -300-fold relative to that in the electrolyte
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Glutathione Methionine Table 1 ) and by -3 x i0 relative to the free ionic silver calculated to be present in SSES (0.00 17 mol/L).
With the artificial serum, a brown precipitate containing silver and sulfur was formed during equilibration, probably the result of degradation products of the protein that had bound the silver.
When human serum was used, similar concentrations of silver were obtained as for the artificial serum at physiological PH; however, no brown precipitate was obtained.
When solid silver chloride was equilibrated with the above solutions, the silver concentrations obtained were similar to those for silver sulfadiazine.
However, silver chloride equilibrated in 0.1 molJL NaNO3 solution yielded different concentrations of silver, consistent with the values calculated from the respective solubility products (see Table 2 ).
Discussion
When either silver sulfadiazine or silver chloride is placed in direct contact with a noninteracting electrolyte solution such as 0.1 mol/L NaNO3, the following general equilibrium is established:
Ag[anion](s)±Ag(aq) + [anion](aq)
the anion in this case being either sulfadiazine or chloride. For silver sulfadiazine, the solubility product at 25#{176}C is 8.12 x 1012 at pH 7-8(4), so the expected value for the concentrations of silver and sulphadiazine would be 2.85 imol/L, similar to that obtained experimentally (see Table 1 ). For silver chloride, the solubility product is 1.56 x 10b0 at pH 7-S (20), so the expected value for the concentration of silver would be 12.5 pmol/L, similar to the mean value of 11.6 .tmol/L obtained experimentally (see Table 2 ). This indicates that silver chloride is about five times more soluble than silver sulfadiazine. 
AgCl(s)
In this case, chloride was the only anion of importance: The other anions in SSES were too low in concentration for silver precipitation to occur. Thus, it seemed that the equilibrium determining the concentration of silver in SSES was:
Using the previous solubility product for silver chloride, we calculated the expected value for the concentration of silver when the chloride concentration is 0.103 mol/L as 0.0017 tmolIL, which differs from the experimental value by -1000-fold.
This difference arises because it is the total soluble silver that has been determined experimentally, whereas the value calculated from the solubility product is for ionic silver only. Silver has the ability to form linear coordination compounds and in the presence of excess chloride the following reaction can occur:
AgC1(s) + Cl(aq)
AgCl(aq)
The equilibrium constant for this reaction is 1 x i0, and although small, it must be considered because the chloride concentration is relatively high. Taking this reaction and equilibrium constant into account, we calculated the total amount of soluble silver as 1.03 jimol/L, which is in good agreement with the experimental value of 1.3 imoIJL (see Table 2 ).
These results indicate that the assumption of silver precipitating at a burn wound as silver chloride is reasonable when a silver preparation is placed on the wound. However, the assumption that silver would not be absorbed because the chloride concentration in serum would suppress its solubility is clearly not tenable. Moreover, many other endogenous ligands in serum are capable of forming much more stable silver complexes than chloride, so the dissolution of silver from silver sulfadiazine in vivo is likely to be much greater than expected.
When potential biological ligands, e.g., glutathione, cysteine, methionine, and histamine (see Fig. 1 ), were added to SSES and either silver salt was equilibrated with the medium, the silver sulfadiazine essentially completely dissociated, releasing silver and sulfadiazine into solution. Similar silver concentrations were observed when silver chloride was equilibrated under the same conditions. Because the released silver is free to react with any ligand (L) in the medium, including chloride, the equilibria involved are:
